Plain-English translation of NCT06625034 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 3 — Testing in thousands of people, comparing the treatment against what doctors currently use. This is the last big step before approval.
This trial is testing whether a computer-based planning system called RapidPlan can plan radiation therapy for prostate cancer just as safely and effectively as a doctor planning it by hand. Both approaches use radiation to treat prostate cancer, but they differ in how the treatment beams are designed before you receive them. The study will track any side effects and quality of life over the first year to compare the two methods.
Radiation therapy is a common, proven way to treat prostate cancer, but planning these treatments takes time and depends on the doctor's expertise. This new computer-based planning system could potentially speed up treatment planning and make it more consistent, while maintaining the same safety record as traditional planning.
You likely qualify if…
You likely don't qualify if…
You will be randomly assigned to receive radiation therapy planned either by computer or by your doctor—both groups receive the same radiation treatment itself. Your actual radiation sessions will take 15–30 minutes each, delivered over several weeks (typically 5 to 44 sessions depending on your treatment plan). You'll also have imaging scans (MRI), blood draws, and PET scans before and during your treatment. After treatment ends, you'll return for follow-up visits at 3 months, 12 months, and then yearly for up to 5 years to check on side effects and quality of life.
AI-generated summary from trial data · Jun 30, 2026 · Not medical advice
United States